Oxytocin
Pick's Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Pick's Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLORTAUCIPIR Molecular NeuroImaging | Phase 1 | CC |
Galantamine Hydrobromide Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 | NR |
Same molecule, other indications
Oxytocin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →